|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 1995;60:299
© 1995 The Society of Thoracic Surgeons
| The first 20% of the full text of this article appears below. |
See also page 292.
DR GIDEON MERIN (Jerusalem, Israel): We also were intrigued by the effect of T3 on myocardial performance in the setting of isolated heart preparation of Langendorff and could establish that it probably works through mediation by calcium channels. This beneficial effect could be abolished completely by the addition of verapamil into the solution.
DR TIMOTHY S. HALL (New Brunswick, NJ): You emphasized a preemptive treatment. Do you have any data on posttreatment alone? Indicate your dosing scheme.
DR WALKER : The initial studies we performed were in
Related Article
Ann. Thorac. Surg. 1995 60: 292-299.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |